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Taylor Ray Mayberry. Neuromodulation of Spinal Pathways Involved in Chronic Pain:
Implications for Motor Rehabilitation. (Under the direction of Nathan C. Rowland).
Lower thoracic dorsal column epidural stimulation is a common intervention in
the treatment of chronic low back and leg pain (CLBLP). This has traditionally been
carried out using low frequency (1-100 Hz) tonic stimulation (LFTS). LFTS has also been
studied in the context of spinal cord injury (SCI) and has been found to selectively
activate motor nerve roots in persons with paraplegia, some of whom have regained
partial ambulation using this technique. A known adverse effect of LFTS is attenuation of
proprioception. Recent advancements in spinal cord stimulation (SCS) technology using
high frequency (1-10 kHz) burst stimulation (HFBS) have demonstrated pain mitigation
comparable to LFTS, however effects on motor neuron and proprioceptive activity using
this new modality are poorly understood. For this thesis work, one individual with CLBLP
underwent electromyography (EMG) recording from lower extremity muscles during
intraoperative SCS placement (Spectra WaveWriter™, Boston Scientific, Marlborough,
MA) to investigate pain mitigation and motor neuron activation in response to HFBS.
Proprioception was also tested extraoperatively using a threshold to detect passive
motion (TTDPM) protocol in which LFTS and HFBS were compared with respect to
perception of movement around the knee joint. Finally, the subject performed a gait task
on an instrumented treadmill while recording EMG from lower extremity muscles and
switching between SCS modalities. Extraoperative SCS testing at rest revealed that
HFBS correlated with a significant increase in EMG amplitude (p < 0.01) and decreased
interpeak interval (IPI) (p < 0.01) of evoked potentials compared to LFTS. TTDPM
showed similarity between HFBS and no stimulation, while LFTS resulted in reduced
capacity to perceive change in passive knee flexion/extension (p < 0.01). EMG analysis
showed thoracic SCS with HFBS, but not LFTS, did not alter normal gait patterns,
including foot swing and step height (p < 0.01). Our results indicate that thoracic HFBS
vii

may influence motor neuron activity without attenuating important proprioception
signaling compared to LFTS and may represent a potential therapeutic modality for
simultaneous treatment of chronic pain and motor recovery using SCS.
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1.0 INTRODUCTION
Chronic low back and leg pain (CLBLP) is a leading cause of disability worldwide,
and an estimated 34,000 spinal cord stimulation (SCS) surgeries are performed annually
to alleviate debilitating CLBLP.1 Approved by the FDA in 1989 for the treatment of
chronic neuropathic pain, SCS modulates excitability of large, low-threshold A fibers
(non-nociceptive) along the dorsal column which synapse onto interneurons that inhibit
ascending pain transmission toward the brain. Although traditional mechanistic
explanations of SCS for treatment of CLBLP, such as the gate control theory, are widely
accepted, stimulator technology that has emerged in the last decade is far less
understood. For example, pain reduction via SCS has traditionally utilized low-frequency
tonic stimulation (LFTS), which is generally applied at frequencies less than 100 Hz and
produces paresthesias (i.e., a tingling sensation) at sensory threshold amplitudes
thought to be necessary for targeting areas of pain. 2 However, recent evidence suggests
that the induction of paresthesias via LFTS may compromise proprioceptive information
flowing from the periphery to the spinal cord, thus potentially adversely modulating spinal
projections involved in motor behaviors such as standing and walking. 3,4 In contrast,
recent studies suggest higher frequencies (e.g., up to 10,000 Hz) and complex
waveforms of stimulation such as high-frequency burst stimulation (HFBS) can attenuate
pain perception without producing paresthesias. Nevertheless, the potential effect of
HFBS on proprioceptive signaling and ability to influence ventral motoneuron (MN) pools
has only recently begun to be investigated.
Motoneurons residing in the ventral aspect of the spinal cord rely on descending
drive from the brain and afferent input from the periphery to shape voluntary movement.5
In 2009, Harkema et al investigated the effects of SCS on MN activation utilizing LFTS
ranging from 5-60 Hz (frequency) in subjects with complete spinal cord injury (SCI).
LFTS of the lumbosacral spinal cord segments (T11 - L2) was found to elicit activation in
2

lower extremity musculature previously thought to be quiescent in these spinal cord
injured individuals. In one subject, surface electromyography (EMG) showed that SCS
facilitated activation of extensors during assisted standing, rhythmic activity during
assisted walking and appropriate modulation of on/off states during assisted weight
shifting tasks.6 Notwithstanding, Formento et al found that LFTS interrupts proprioceptive
sensory information from the lower extremities that helps shape motor activity. The
amount of compromised afferent information during traditional spinal cord stimulation via
LFTS was postulated to be dependent on the quantity of dorsal column primary afferents
recruited and proportional to increases in current and pulse width.3 In the Formento
study, 3 subjects were implanted with a 16-contact epidural paddle array and
implantable pulse generator (IPG) (Activa RC, Medtronic, Fridley, Minnesota) along the
lumbosacral spinal cord (T11 – L2). Proprioception was tested using an isokinetic
dynamometer to passively flex and extend the knee while subjects were seated. Knee
flexion/extension was applied until subjects reported perceiving movement. Compared to
no stimulation, LFTS parameters (15-100 Hz, 210–450 s, 4.5–9.0 mA) were found to
cause a significant loss (p < .05) of perceived position sense during passive movement
when stimulation amplitudes were high enough to innervate their homonymous motor
neuron pool to activation threshold (as measured by EMG). Interestingly, in the same
study, although the epidural stimulator used during proprioceptive testing was only
capable of stimulating at 125 Hz, by interleaving 4 stimulation programs with a 2 ms
delay the group was able to create a 4-pulse 500 Hz bursting pattern. HFBS at 500Hz
was found to elicit motor neuron activation with a 39.8% reduction in current amplitude
when compared to 20 Hz LFTS. These two studies together demonstrate that while SCS
is designed to directly modulate dorsal column pathways, a better understanding of
exactly how fibers and neuronal pools are stimulated might possibly allow activation of
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both ventral and dorsal columns in a way that benefits motor and sensory information
processing.
Since the epidural space is exposed during surgical placement of the SCS
device, information about a subject’s motor and sensory spinal pathways can be easily
obtained during the regular course of the procedure and compared to proprioceptive and
motor responses once the subject is awake and moving with the device turned on. Our
lab specializes in electrophysiological recordings in subjects undergoing spinal cord
stimulator (SCS) implantation for CLBLP, while the Locomotion Laboratory at the
Medical University of South Carolina (MUSC) specializes in quantifying proprioception
and movement in human subjects. In order to examine potential differences in
modulating sensorimotor pathways between traditional LFTS and newly developed
HFBS parameters, this project investigated 3 specific aims:
Aim 1. Investigate the effect of LFTS on sensory thresholds intraoperatively.
Question: Does LFTS modulate the activity of ascending sensorimotor pathways?
In this aim, we measured somatosensory evoked potential thresholds in a subject
undergoing SCS implantation during stimulation of epidural paddle contacts. We
hypothesized that LFTS would reduce somatosensory evoked potential thresholds.
Aim 2. Determine the effect of HFBS on proprioceptive afferent signaling from the
lower extremities. Question: Does HFBS, when compared to traditional LFTS, allow
for increased spatial limb awareness during passive motion? In this aim, the
postoperative subject from SA1 underwent isokinetic passive proprioceptive testing
before and during spinal cord stimulation with HFBS and LFTS parameters targeting
sensation surrounding the knee. We hypothesized that the subject would have increased
awareness of the lower limb in space through passive movement during optimal HFBS
compared to optimal LFTS parameters.
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Aim 3. Determine the effect of HFBS on lower extremity muscle activity during
gait. Question: Does HFBS, when compared to LFTS, differentially affect muscle
synergy patterns during gait? In this aim, the subject from SA1 and SA2 performed
treadmill walking before and during SCS stimulation. The subject was monitored with
surface EMG and 3-D kinematic tracking software to quantify changes in gait pattern.
We hypothesized that the subject would have increased EMG module complexity during
gait with HFBS compared to LFTS or no stimulation.
If we are able to identify HFBS parameters that preserve proprioceptive signaling
while attenuating pain, in future studies we may be able to apply these parameters for
simultaneous treatment of neuropathic pain and movement rehabilitation in patients with
chronic motor dysfunction, such as those with spinal cord injury and stroke.

1.1 PAIN SIGNALING
Pain signaling involves nociceptor-triggered action potentials along Aδ and C
primary

afferent

fibers in response
to

physical

and

chemical

insult

(Fig.1). As a result
of

activation

nociceptive

fibers,

glutamate
substance
released

of

and
P

are
within

Figure 1: Image and caption modified from [7]. Illustration of nociceptive signaling to the
dorsal horn of the spinal cord.

lamina I and II of the dorsal horn of the spinal cord (DHSC)(Fig. 2). 9,10
5

Within

the

DHSC,

2nd

order fibers carrying pain signals
cross the midline and ascend as
part of the anterolateral system
(i.e., spinothalamic, spinoreticular
and spinomesencephalic tracts)
where axons synapse within the
midbrain and thalamus for pain
perception processing.11
1.1.1 CHRONIC PAIN
Chronic pain is defined by
the International Association for
the Study of Pain (IASP) and
World

Health

Figure 2: Image and caption modified from [8]. Illustration of lamina IVI of the DHSC, with nociceptive C-fibers terminating in lamina I-II.

Organization

(WHO) as pain that persists beyond the normal time of healing and is clinically
recognized by debilitating pain longer than three months in more than one anatomical
location (e.g., low back and leg).12 Chronic pain was identified as one of the top causes
of disability in the world in the 2017 Global Burden of Disease Study compiled by the
Institute for Health Metrics and Evaluation.13 Chronic pain may be further delineated into
a subcategory of pain relating specifically to damage of the peripheral or central nervous
system. The current International Classification of Diseases (ICD-11) defines chronic
neuropathic pain as pain caused by a lesion or disease of the somatosensory nervous
system.14 Chronic neuropathic pain is generally thought to be caused by dysregulation of
nociceptive signaling and can lead to normal mechanical stimuli being perceived as
painful (allodynia) or painful stimuli being perceived as a much higher intensity of pain
6

(hyperalgesia). Plasticity in the neuron, interneuron, microglia and astrocyte complexes
within the DHSC stemming from repeated exposure to glutamate and substance P
release is thought to play critical roles in this dysregulation.15 Existing homeostatic
mechanisms used to regulate pain perception may be altered in persons suffering from
chronic pain. Inhibitory interneurons within the superficial laminae of the DHSC have
GABAergic projections to 2 nd order neurons responsible for modulating pain
transmission to higher brain centers. These inhibitory interneurons are thought to be
regulated by primary nociceptive (Aδ and C) and mechanoreceptor (Aβ) afferent fibers,
with loss of this tight regulation leading to excessive pain perception. Another potential
mechanism of chronic pain suggests involvement of the inflammatory cascade. In
rodents, Substance P injection showed significant decrease in pain response time (p <
.05) to painful stimulus applied to the hind paw compared to saline injection.16 In
humans, Hagermark et al showed a localized inflammatory response to intradermal
injection of substance P.17 Using transgenic mice that allowed for ablation of microglia
expressing CX3CR1+ (chemokine receptor), Peng and colleagues investigated the role of
microglia within the DHSC following spinal nerve transection (SNT). Immediately
following SNT, hind paw withdrawal reflex to noxious thermal stimuli showed no
significant difference among control and microglia ablated mice. However, three days
post-SNT, control mice showed significant decrease in withdrawal latency to noxious
stimuli (p < .001) compared to the knockout group.18 Together, these studies indicate
that inflammatory response from acute peripheral nerve injury may facilitate cellular
changes that increase excitability of nociceptive pathways and highlight the complex
chain of events involved in the transition of acute to chronic pain.

7

1.1.2 GATE CONTROL T HEORY
Important work published in 1965 by Melzack et al on the relationship between
mechanosensory afferents and pain
within the DHSC continues to serve
as the best accepted model for the
regulation of pain signaling nearly a
half-century later. Known as the
Gate Control Theory (GCT), Melzack
postulated that Aβ fibers inhibit 2nd
order

pain-signaling

neurons

resulting in reduced transmission of
these

signals

to

higher

Figure 3:
3:Image
Image and
and caption
caption modified
modified from
from [8].
[8]. Model showing a
simplified mechanism of pain projection inhibition through Aβ fiber
activation of dorsal horn inhibitory interneurons

order

centers. (Fig.3).19 According to Melzack’s theory, this reduction involves inhibitory
interneurons within the DHSC. Clinicians tested Melzack’s theory by directly modulating
Aβ fiber axons along the dorsal column pathway using electrical current, eventually
leading to the development of spinal cord stimulation (SCS) as an effective intervention
for CLBLP.20
1.2 SPINAL CORD STIMULATION PARAMETERS FOR CHRONIC PAIN
SCS is currently used to treat chronic neuropathic pain that may arise from spinal
injury, disease, and/or previous spinal surgery, for example, in cases of postlaminectomy syndrome, the most common indication for SCS. SCS surgery represents
70% of all neuromodulation cases in the United States and is expected to grow as the
intervention shows continued promise to successfully treat neuropathic pain from these
and many other etiologies.1 The SCS procedure for CLBLP involves lower thoracic
placement of epidural electrodes via laminectomy that, when activated, excite Aβ fibers,
producing a paresthetic sensation along the region of pain. Traditional application of
8

SCS utilized a pattern of
electrical impulses known
as

tonic

stimulation,

(constant)
which

is

comprised of three main
parameters

that

in

combination determine the
intensity of the stimulus:
frequency

(Hz),

Figure 4: Image and caption modified from [21]. Illustration of tonic stimulation
parameters of frequency, pulse width and amplitude.

pulse

width (µs) and amplitude (mA) (Fig.4).
Newer

stimulator

technology

has

led

to

the

development of implantable pulse generators (IPG) (Fig.5),
such as the SPECTRA WaveWriter (Boston Scientific,
Marlborough, MA), that delivers electrical current to the
epidural contacts in a complex waveform at frequencies up to
Figure 6: Image modified from
[22].
Image
of
Spectra
Wavewriter IPG manufactured by
Boston Scientific (Marlborough,
MA). Blue box highlights the
connection
ports
for
the
stimulator paddle.

10 KHz (Fig.6). Although the majority of patients receiving
SCS for chronic pain find the paresthetic effect of lowfrequency tonic stimulation (LFTS) more tolerable than pain
itself, these complex waveforms, known as high frequency

burst stimulation (HFBS), have been found to attenuate pain with equal or greater

Figure 5: Image and caption modified from [21]. Illustration of SCS parameters for A) tonic stimulation and
B) additional parameters for HFBS being interburst frequency and intraburst frequency.
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effectiveness without producing paresthesias. In 2015, a large, multi-center, randomized
control trial (SENZA-RCT) was conducted to assess the efficacy of high frequency tonic
stimulation (HFTS) at 10 KHz using the Senza IPG (Nevro, Redwood City, CA) in
patients with chronic pain of the trunk and/or limbs. The trial consisted of 171 subjects
receiving surgical placement of an SCS paddle and IPG. Ninety subjects received the 10
KHz-capable IPG and 81 subjects received IPG implants capable of producing traditional
tonic stimulation of < 1 KHz. Over 12 months, subjects who received the Senza device
experienced stimulation at a frequency of 10 KHz with a 30 s pulse width and
stimulation amplitudes ranging from 1.6 – 3.8 mA, while subjects receiving traditional
SCS underwent stimulation at a frequency of 39.2 – 133.5 Hz, pulse widths of 347 – 591
s and stimulation amplitudes ranging from 3.6 – 8.5 mA. After 12 months of stimulation
both groups were assessed for pain relief via Visual Analog Scale (VAS) of 0 / 10, where
10 is severe debilitating pain and 0 is no pain. Subjects receiving 10 KHz stimulation
reported a decrease in VAS from 7.4 ± 1.2 to approximately 2.5, a 67% decrease with no
reports of paresthesia, whereas subjects receiving traditional LFTS reported a decrease
in VAS from 7.8 ± 1.2 to approximately 4.3, a 44% decrease in pain rating (p < .001) with
all subjects perceiving paresthesias.23
Another study investigating efficacy of HFBS for chronic pain was conducted in
2017 by Deer et al, in which 100 subjects participated in a randomized crossover trial
(SUNBURST). All subjects that qualified for the study were implanted with the Prodigy
SCS IPG manufactured by Abbott (Plano, TX). After surgical placement of the SCS
paddle and IPG, subjects were initially programmed with tonic stimulation settings of
frequency ranging from 30 – 100 Hz, pulse width of 100 – 500 s and stimulation
amplitudes tailored per each subject according to elicitation of comfortable paresthesias
over the region of pain. Subjects were then separated into two treatment groups, where
10

one group of 45 subjects continued use of tonic stimulation and the other 55 subjects
received HFBS with an intraburst frequency of 500 Hz, interburst frequency of 40 Hz,
and pulse width of 1 ms delivered in packets of 5 pulses. Each treatment group received
their assigned treatment for a total of 12 weeks before the groups were switched to the
opposite stimulation type. Following 24 weeks of study, the average amplitude of LFTS
was 6.42 ± 4.00 mA while the average amplitude for HFBS was 1.73 ± 1.05 mA (p <
.05). The primary outcome measure was perceived pain using a 100 mm VAS, where 0
is no pain and 100 is severe debilitating pain. At the end of 24 weeks, a significant
difference was found in favor of HFBS with a 5.1 mm difference between HFBS and
LFTS regarding VAS rating, and 70.8% of subjects expressed a preference for HFBS
over LFTS (p < .001).24 These two important studies highlight the increased capability of
advanced waveform SCS to mitigate pain when compared to traditional stimulation
parameters.
1.3 PROPRIOCEPTION SIGNALING
Muscle
contain

spindle

specialized

fibers

receptors

located within skeletal muscle that
sense

the

length

and

stretch

velocity of extrafusal muscle fibers.
Proximally, muscle spindles form
primary sensory afferents (Ia and II
fibers) that project through the
dorsal root ganglion (DRG) to the
DHSC and then bifurcate, with
ventral

projections

influencing

Figure 7:
7: Image
Image and
and caption
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Circuitry diagram
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Figure
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(Ia) signaling
signaling leading
leading to
to A)
A) excitation
excitation of
of
of
homonymous
homonymous muscle,
muscle, B)
B) inhibition
inhibition of
of antagonist
antagonist muscle,
muscle, C)
C)
excitation of
of synergist
synergist muscles
muscles and
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via dorsal
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column.pathway.
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−motor neurons (Fig.7) and ascending tracts within the dorsal column and posterior
spinocerebellar tracts of the spinal cord projecting to nuclei of the medulla and cerebellar
cortex respectively. Muscle spindle afferents have been shown to influence −motor
neurons in three ways: 1) monosynaptic excitation, 2) disynaptic excitation and, 3)
disynaptic inhibition.25,26,27
Golgi tendon organs have receptors located at the insertion of extrafusal muscle
fibers with connective tissue of a tendon that sense changes in muscle tension. Primary
sensory afferents (Ib fibers) also project through the DRG to the DHSC and then
bifurcate, with ventral projections influencing inhibitory and excitatory interneurons and
ascending tracts along the dorsal column and anterior spinocerebellar tracts of the spinal
cord. The disynaptic effects of Ib fibers on −motor neurons have been previously
studied in humans by Dietz and colleagues using a body weight support crane to reduce
load

during

walking

on

a

treadmill

while

simultaneously

recording

surface

electromyography (EMG). In healthy controls, reduction in body weight of 50% was
shown to cause significant decrease in extensor muscle activation amplitude during late
stance when compared to subjects walking with full body weight ( p < .05 ). 28 This finding
suggests that muscle tension information conveyed by Ib fibers of the golgi tendon organ
influences homonymous muscle activation during walking in an excitatory fashion.
Sensory afferent modulation of MN excitability is also facilitated by pain signaling
in Aδ fibers, resulting in a withdrawal reflex to noxious stimuli. Withdrawal from
cutaneous afferent activation was investigated in 1999 by Andersen et al, where 14
healthy subjects received noxious electrical stimulation on the sole of the foot in 16
different locations while sitting upright. Stimulation was delivered at 1.5x subject pain
response threshold according to the visual analog scale (VAS), guaranteeing Aδ fiber
recruitment. Surface EMG recording of the gastrocnemius medialis (GM) and tibialis
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anterior (TA) muscles along with kinematic changes in ankle position using a goniometer
were collected during stimulation. Stimulation of the distal medial sole elicited robust TA
activation along with a 6 mean dorsiflexion response, however stimulating the heel
region of the sole resulted in GM activation and a 2 mean plantarflexion movement. A
significant difference was found between muscle activation (p < .001) and kinematic
response (p < .001) to noxious stimuli delivered to different regions along the sole of the
foot.29 The observations of Andersen and colleagues demonstrate that cutaneous
afferent fibers influence MN excitability with modular organization, indicating diverse
projections to both excitatory and inhibitory interneurons that may influence motor
behavior in someone with chronic pain.
Spaich and colleagues investigated MN response to noxious stimuli during gait.
Electrical stimulation, above individual pain threshold, was delivered on the sole of the
foot for 15 healthy individuals during 4 different phases of the gait cycle being 1) heel
contact, 2) mid-stance, 3) early swing and 4) late swing. Knee angle measurements
using a goniometer were continuously recorded during 30 seconds of walking at 3 km/h.
The magnitude of knee flexion was found to be significantly smaller from stimuli
delivered during the heel contact and mid-stance phases compared to early swing and
late swing (p < .05).30 The lack of knee flexion observed during load bearing portions of
the gait cycle suggests that withdrawal reflex responses to pain may be modulated, at
least in part, by proprioceptive signaling during a functional task. Thus, primary afferent
sensory signaling from muscle spindle fibers, golgi tendon organs and Aδ fibers
influence −MNs and interneurons of the VHSC during functional motor tasks, tightly
regulating muscle firing to maintain appropriately timed contractions of agonist and
antagonist muscles around a joint.
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1.4 M USCLE ACTIVATION PATTERNS DURING GAIT
Persons with neurologic insult due to stroke or incomplete SCI can produce
robust activation of individual flexor or extensor musculature in certain experimental
conditions. However, in many cases what is
lost in these disorders is the ability to
produce fine-tuned, integrated movements
necessary for dynamic tasks such as
walking.31 A module-based approach to
quantify gait patterns was first applied to
humans

in

2004

by

Ivanenko32, and

subsequent work performed in 2010 by
Clark et al established that gait could be
represented in four modules. The four
modules implemented by Clark represent
four phases of the gait cycle: 1) Early
Stance, 2) Late Stance, 3) Early Swing,
and 4) Late Swing.

[29]. Illustration
Figure 8: Image and Caption modified from [31].
of module classifications using groupings of muscle coactivation
amplitude (grey
(grey shading)
shading) during
during a
a walking
walking task
task in
in
activation amplitude
20 healthy subjects with group mean (black box). Muscle
weightings are shown for tibialis anterior (TA), soleus (SO),
medial gastrocnemius (MG), vastus medialis (VM), rectus
femoris (RF), lateral hamstring (LH), medial hamstring
(MH) and gluteus medialis (GM).

EMG-based module groupings during a typical gait cycle are illustrated in Figure
8, where early stance shown in module 1 is representative primarily of extensor activity
for weight acceptance with activation seen in the vastus medialis (VM), rectus femoris
(RF) and gluteus medius (GM). Module 2 represents the late stance phase when
plantarflexors are active for forward propulsion, facilitated by muscle activity in the
soleus (SOL) and medial gastrocnemius (MG). Module 3, the early swing phase, shows
muscle activity primarily in flexors of the hip (rectus femoris or RF) and ankle (tibialis
anterior or TA). The late swing phase of the gait cycle, module 4, is during deceleration
of the limb for proper foot placement and is facilitated by increased muscle activity in the
14

medial and lateral hamstrings (MH) (LH). The ability to coordinate timing-dependent
muscle co-activations during functional tasks, such as walking, remains dependent,
however, on appropriate sensory feedback. Recently, Wagner and colleagues
postulated that SCS delivery in a spatio-temporal, rather than tonic, fashion would
increase rehabilitation potential in persons with incomplete spinal cord injury due to
sparing of important proprioceptive signals by minimizing the amount of time when SCS
is on. The spatio-temporal SCS method involves activation of contacts targeting specific
posterior nerve roots to recruit musculature facilitating gait in a time-dependent fashion,
thus allowing natural sensory afferent signaling to reach the spinal cord when SCS is not
needed and inactive. In their study, SCS implantation over the lumbosacral spinal cord
(T11 – L2) segments was performed on three male subjects with chronic cervical SCI
with severe lower limb deficits. Subjects underwent 15 weeks of assisted over-ground
treadmill walking during spatio-temporal LFTS using a dynamic body weight support
system. Following 15 weeks of training, subjects performed a walking task during no
stimulation, LFTS, and spatio-temporal LFTS with full body kinematic tracking allowing
quantification of step height (cm) and walking speed (m/s). A significant increase in step
height (p < .001) and walking speed (p < .01) were found in all 3 subjects during spatiotemporal LFTS supporting their initial hypothesis that primary afferent sensory sparing is
fundamental to produce proper gait mechanics. A six-minute walking test was used to
assess ambulation recovery following step training with spatio-temporal SCS. One
participant increased walking distance from 60 meters to 150 meters while another
participant increased from 10 meters to 60 meters. The third participant was unable to
complete unassisted walking, however by using a walker he was able to increase
walking distance from 0 meters to 300 meters. 33 In a companion study investigating SCS
effects on proprioception, Formento and colleagues created a computational model of
proprioceptive afferent recruitment in response to SCS. The same model used to
15

indicate the potential benefit of spatio-temporal LFTS also showed a similar benefit using
HFBS at 600 Hz.3 At the time of these two studies, SCS technology did not allow for
testing of HFBS parameters at this frequency.
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2.0 M ATERIALS AND M ETHODS
2.1 SCS PADDLE PLACEMENT AND ACTIVATION
This study was approved under IRB protocol # Pro00089881. The subject was
consented for placement of a spinal cord stimulator paddle for treatment of chronic low
back and leg pain. The subject was informed that during the procedure EMG and SSEP
data would be collected and saved at various points during placement. SCS placement
was performed using a 32-electrode paddle array (CoverEdge™, Boston Scientific,
Marlborough, MA) (Fig.9) implanted at the T7-9
vertebral levels.
The subject was first placed under
general anesthesia and positioned prone on the
operating room table. Subdermal SSEP and
EMG needle electrodes were placed throughout

Figure 9: Boston Scientific CoverEdge™ 32
Surgical Lead (left) and fluoroscopic image of
the stimulator array after implantation along the
dorsal epidural space (right).

the subject’s body by the neurophysiology team
as determined by standard of care guidelines.
2.2 SHORT- LATENCY SOMATOSENSORY EVOKED POTENTIAL (SSEP)
SSEP testing of the lower extremities is most commonly performed on the
posterior tibial nerve (PTN). Cortical responses to PTN stimulation are recorded using
scalp electrodes that are placed according to the 10-20 International System used for
electroencephalography (EEG) recordings. Electrodes are placed at CPz (centroparietal), C3 (left motor cortex), C4 (right motor cortex), and C5 (brainstem). The initial
cortical waveform seen during PTN stimulation is a positive deflection approximately 37

Figure
10: Visualization
Visualization of
of baseline
baseline SSEP
SSEP averaging
averaging from
from PTN
PTN stimulation
stimulation recorded
recorded
Figure 10:
by
by the
the 10-20
10-20 International
International System.
System. The
The two
two teal
teal crosshair
crosshair markers
markers represent
represent the
the
deflections.
deflections. Waveform represents average response to SSEP stimuli (n = 200).

between C4-C3
C4-C3 as
between
as defined
defined
P37
P37 (left)
(left) and
and N45
N45 (right)
(right)

17

milliseconds after stimulation (P37), followed by a negative deflection approximately 45
milliseconds after stimulation (N45) (Fig.10).34 In this study, PTN stimulation and cortical
recordings via scalp electrodes were performed using the IOMAX intraoperative
neuromonitoring platform (model number 100880-937, Cadwell, Kennewick, WA).
Cortical voltage data were sampled at 250 Hz, bandpass filtered between 30 – 500 Hz
and responses were averaged every 200 SSEP pulses to calculate averaged
waveforms.
2.2.1 SSEP COLLISION T ESTING
SSEPs provide a surrogate measure of the sensory activation threshold of dorsal
column fibers and can be affected by limb length, body temperature, SCI, spinal
stenosis/compression, demyelination and neuropathy. The SSEP latencies described
above can also be modulated by SCS through epidural paddle electrodes using a
technique known as SSEP Collision Testing. SSEP pulses delivered at a rate of 2.79 Hz
with an amplitude of 40 mA will show a decrement of the P37 and N45 deflections as the
parameters of the epidural stimuli are altered. To accomplish this, SCS was delivered at
a 40 Hz rate with a 300 s pulse width at a starting amplitude of 1.0 mA and increased in
increments of 1.0 mA until SSEP attenuation occurred, which is confirmed by a 100%
loss of the P37 waveform.
2.3 ELECTROMYOGRAPHY (EMG)
EMG is used to record motor unit
activation. The motor unit is comprised of a
single motoneuron (MN) and the muscle fibers
innervated by that MN (Fig.11).35 The muscle
fibers innervated by the MN are, like most cells,
semi permeable structures tightly regulated via

Figure 11: Image and caption adapted from [33].
[35].
Illustration of a single Motor Unit.
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voltage-gated ion channels that at rest allow for flow of potassium (K+) ions out of the
membrane and restriction of sodium (Na+) ions from entering the cell, resulting in a
membrane potential of ~ -80mV.
When a lower MN is activated, the neurotransmitter acetylcholine (ACh) is
released from motor endplate presynaptic terminals, facilitating conformational changes
in the voltage-gated channels of muscle fibers leading to Na+ influx and rapid
depolarization. The wave of depolarization along a group of coactivated muscle fibers
forms

an

electric

dipole and, with the
application of bipolar
electrodes placed on
the skin, underlying
muscle activity can be
captured

as

a

potential difference in
voltage between the

Figure
12:Image
Imageand
and caption
caption modified
modified from
from [32].
[35]. EMG
EMG electrode
electrode setup
setup used
used to
to capture
capture
Figure12:
electrical signals from underlying muscle tissue.

electrodes. Illustrated
in Figure 12, a wave of depolarization moves along the muscle fibers along several time
points (T1-T5), where sensing electrodes, outlined in green boxes, connected to an
amplifier record the potential difference (blue sinusoid) in samples of voltage, resulting in
both positive and negative deflections in the EMG of equal amplitudes.
2.3.1 EMG RECORDING DURING SCS ACTIVATION
In the present study, we performed epidural paddle stimulation while monitoring
EMG activity. The SCS parameter used were the same LFTS parameters found to
attenuate the P37 and N45 deflections during the aforementioned SSEP collision testing.
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Following LFTS, two other parameter settings were tested at the same amplitude
including: HFBS with 600 Hz intraburst / 40 Hz interburst and HFBS with 1200 Hz
intraburst / 40 Hz interburst (Fig.13).
EMG was collected
intraoperatively using 13 mm
stainless

steel

subdermal

needle electrodes (model #
RLSP310,

Rhythmlink

International, Columbia, SC)
at a sampling rate of 3 kHz
Figure 13: Visualization of EMG tracings during different SCS stimulation
parameters. Illustration is derived from stimulator artifact captured via
subdermal needle EMG electrodes placed in the Rectus Abdominus.

using a 16-channel recording
device

(LR10™,

Tucker

Davis Technologies, Alachua, FL) that served as a signal amplifier and analog-to-digital
converter. EMG was recorded bilaterally from three lower extremity muscles (Vastus
Lateralis (VL), Tibialis Anterior (TA), Soleus (SL)) and rectus abdominus muscles to
allow for visualization of stimulator artifact (Fig.14). During extraoperative EMG
measurements, 15 x 20 mm conductive vinyl surface EMG self-adhesive electrodes
(model # PSTCUL15026, Rhythmlink International, Columbia, SC) were placed on the
skin over the same muscles tested intraoperatively.
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Figure 14: Visualization of musculature chosen for EMG recording during SCS activation.

Following intraoperative testing, the subject was given at least 30 days to recover
before being asked to return for further extraoperative SCS testing using surface EMG
as described above. Given that during intraoperative procedures the subject was placed
under general anesthesia, performing extraoperative SCS allowed for feedback
regarding sensory thresholds and quality of pain reduction from LFTS and HFBS
parameters. Extraoperative EMG recording was performed at perceived sensory
threshold, 1.5x perceived sensory threshold and 2x perceived sensory threshold for
each SCS parameter tested. Perceived sensory threshold was established by increasing
SCS amplitude in increments of 1.0 mA per parameter set until the subject verbally
reported sensation of the stimulation. Perceived sensory threshold measurements and
surface EMG were collected while the subject was awake and side-lying.
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2.3.2 EMG PROCESSING AND ANALYSIS
EMG signals at rest (both intra- and extraoperative) were high-pass filtered
above 10 Hz (MATLAB®, Mathworks, Natick, MA). The frequency of an EMG signal
typically ranges from 0 – 500 Hz, however true muscle activity may be hard to visualize
without application of a filter. A 10 Hz high-pass filter is commonly used to attenuate
noise from background muscle activity. Voluntary movement and movement of the EMG
leads can also contribute significant noise. Although the subject was under general
anesthesia during intraoperative SCS testing, noise below 10 Hz was observed in the
signal presumably from the movement of EMG leads and the use of a compression cuff
on each leg during surgery to prevent blood clots. Therefore, EMG signals recorded
during intraoperative and extraoperative SCS were filtered in the same manner. All EMG
data collected at rest were resampled to 1 KHz.
Once the subject completed both intraoperative and extraoperative SCS
sessions with EMG recording, peaks in the EMG time series were examined for evoked
potentials, which
typically has a triphasic response
(Fig.15). Evoked
potential peaks in
the

time

series

were identified as
a

positive

deflection in the
EMG of at least
30
Figure 15: Illustration of Top) evoked potentials in EMG signal, Middle) selection of evoked
Figure
15:peaks
Illustration
of Top) evoked
potentials
in EMGreaching
signal, Middle)
selection
evoked
potential
(red circles)
with positive
deflections
threshold
(blue of
line)
and,
potential
peaks
(red of
circles)
with
positive deflections reaching threshold (blue line) and,
Bottom) IPI
histogram
selected
potentials.
Bottom) IPI histogram of selected potentials.

V
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baseline.34 Figure 16 illustrates several examples of evoked potentials in the EMG signal
(top) identified by our algorithm (middle). The signal in each channel was assumed to
arise from a single source. This is confirmed using a histogram of the interpeak intervals
as shown in the bottom panel.
2.4 PROPRIOCEPTION TESTING
We investigated the perceived change in knee joint angle and direction of
movement reported by the subject using a Threshold to Detect Passive Movement
(TTDPM) task (System 4 Pro™, Biodex Medical Systems, Shirley, NY).3,35 The TTDPM
protocol, which utilizes an isokinetic/isometric dynamometer, began with the subject
sitting in the Biodex testing seat and the tested leg strapped to the rotating arm of the
dynamometer at the lower shank with the non-tested leg resting with approximately 90
of knee flexion (Fig.16). In order to prevent
the

subject

direction

from

and

witnessing

initiation,

approximate

distance

traveled of the shank, the subject wore a
blindfold and headphones playing a pink
background noise. Pink noise is defined as
noise in which the power spectral density
of the signal is inversely proportional to the
frequency, thus the amount of energy is
consistent along all frequencies. Pink noise
Figure 16: Image and caption modified from [35]. Illustration
of the TTDPM using a Biodex Dynamometer

is bandpass filtered between 20-20,000 Hz

and is designed specifically to mask electrical noise produced by the Biodex
dynamometer.
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The TTDPM consisted of at least 10 trials for each stimulation condition, with the
dynamometer moving at a rate of 1/second in a randomized flexion / extension
direction. The subject controlled a handheld switch that immediately halted movement of
the dynamometer arm, which was to be activated once the subject perceived movement
or if the subject began to feel any pain or discomfort throughout the task. Once the
dynamometer arm was stopped, the change in knee angle was recorded by the Biodex
software. The subject in this study reported discomfort during passive right hip flexion,
therefore TTDPM testing was only performed on the left leg. The SCS paddle was
activated along the leftmost column of contacts on the epidural paddle, with the bottom
left contact selected as the anode (+) and the superior 7 contacts equally distributed as
cathodal (-) contacts. Both LFTS and HFBS over the chosen contacts produced
paresthesias in reported areas of the patient’s chronic pain in the left leg, thus the
subject was blinded to stimulation modality. SCS amplitudes were identified during
sensory threshold testing, and 1.5x sensory threshold was chosen as the experimental
amplitude for each parameter set due to the potential for discomfort with higher
stimulation amplitudes during prolonged testing.

2.5 W ALKING T ASK AND MODULE CLASSIFICATION
Following proprioceptive testing, the subject performed a
walking task at the 800 sq. foot Locomotor Energetics &
Assessment Laboratory at the Medical University of South Carolina
(MUSC).

A

thoracic

harness

(model

#

M120,

Robertson

Mountaineering, Fort Collins, CO) anchored to the ceiling over the
floor-mounted

treadmill

(FIT,

Instrumental

Treadmill,

Bertec,

Scotland, U.K) was used to safeguard against a potential fall (weight
Figure17:
Figure
17: Subject
Subject fitted
with LED markers during
walking task.

limit = 300 lbs). Vertical ground reaction forces were recorded from
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the treadmill in order to determine gait cycles, where heel strike and toe off were
thresholded at 20 newtons or greater. Kinematic tracking was performed using LED
markers placed over 64 anatomical regions of interest (Fig.17), allowing a 16-camera
motion capture system (Impulse, PhaseSpace, San Leandro, CA) mounted throughout
the room facing the treadmill to collect time-stamped positional data throughout the task.
Marker coordinates were recorded at 120 Hz. The orientation of each tracked segment
was obtained through a least-squares approach by matching the marker locations in the
segment's reference frame to the marker coordinates in the global reference frame. The
pose of segments with less than 3 visible markers could not be calculated. Surface EMG
(model DE 2.1, DELSYS Incorporated, Natick, MA) using 99% silver electrodes was
recorded bilaterally from the gluteus medius, semimembranosus, biceps femoris, vastus
medialis, rectus femoris, tibialis anterior, soleus and medial gastrocnemius. EMG was
sampled at 2,000 Hz using a 32-channel recording device (MA300 system, Motion Labs,
Baton Rouge, LA) and high pass filtered at 40 Hz. Observed EMG signals recorded
during walking exhibited higher degrees of noise from dynamic movement, therefore a
larger high pass filter than that used for EMG data collected during SCS testing at rest
was used.
The subject was asked to walk at a normal pace for one minute per tested
condition, with the initial 10 seconds being used to optimize steady-state walking
conditions and the remaining time to be used for capture of at least 10 consecutive
steady state gait cycles. Trials included baseline recording during gait with no SCS
stimulation, 600 Hz HFBS with a 40 Hz inter-burst and 140 s pulse width, and 40 Hz
LFTS with a 140 s pulse width. Both SCS parameters tested were applied at their
respective 1.5x sensory threshold amplitudes found prior to proprioception testing.
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Segments of EMG recorded during walking at self-selected walking speed were
used to investigate complexity of muscle synergies using a nonnegative matrix
factorization (NNMF) algorithm (MATLAB®, Mathworks, Natick, MA). The approach
illustrated in figure 18 involves calculation of an mxt matrix of the original EMG data
(EMG0), where m represents the number of muscles being measured and t represents a
time base normalized to percentage of gait cycle. The algorithm also calculates two
surrogate matrices, mxn and nxt, where n is the amplitude of muscle activation.31 The
product of the surrogate matrices are considered a reconstruction of EMG (EMGr). EMGr
for each module is then compared to EMG0 by finding the variability accounted for (VAF)
(Equation 1).
(𝑉𝐴𝐹 = 1 − [𝐸𝑀𝐺𝑜 − 𝐸𝑀𝐺𝑟]2 /𝐸𝑀𝐺𝑜2 )
VAF was applied for all 8 eight muscles and across 6 phases of the gait cycle (1 first double support, 2 - first half of ipsilateral single leg stance, 3 - second half of

Figure
18: Figure
Figure taken
taken from
Figure 18:
from Clark
Clark et
et al
al [29].
[29]. Illustration
Illustration of
of the
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the iterative
iterative NNMF
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ipsilateral single leg stance, 4 - second double support, 5 - first half of ipsilateral swing, 6
- second half of ipsilateral swing), where a threshold necessary for module classification
was chosen to be 90% for all 14 conditions (8 muscles + 6 phases of gait) based on
similar studies in the literature.31,38 Classifications were not increased unless the higher
module VAF was at least 5% higher than the preceding module. In Clarke’s study, the
lowest EMG moduling complexity was 2 and represents a gait pattern characterized by
high tone throughout the lower extremities and dominated by the stance and swing
phases. The gait pattern of these individuals is severely impaired. An EMG moduling
complexity of 4 represents normal gait pattern and muscle activations.
2.6 STATISTICAL ANALYSIS
All statistical tests were performed using (MATLAB®, Mathworks, Natick, MA).
Data were tested for normality using an Anderson-Darling normality test. For aim 2, a
non-parametric Kruskal-Wallis test was used to compare EMG amplitude and interpulse
interval (IPI) during extraoperative SCS testing to determine sensory threshold. We
compared three groups: 40 Hz LFTS, 600 Hz HFBS and 1200 Hz HFBS. Also for aim 2,
TTDPM values were analyzed using a one-way ANOVA to compare data recorded
during no stimulation, HFBS and LFTS. In aim 3, step height data collected during the
walking task were analyzed using a one-way ANOVA to compare effects from no
stimulation, HFBS and LFTS. All error bars and shading represent standard error.
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3.0 RESULTS
Our study involved a 74-year-old male subject with chronic neuropathic pain of
the lower back and bilateral legs (left worse than right). The subject was previously
diagnosed with lumbar radiculopathy and had undergone multiple thoracic spine
surgeries. Pain severity was rated at 8 / 10 on a Numeric Rating Scale (NRS) ranging
from 0-10 with 0 being no pain and 10 being severe disabling pain. The patient had
failed conservative measures, including physical therapy. He was referred to Dr.
Rowland

for

evaluation

for

spinal

cord

stimulator.

He

underwent

a

full

neuropsychological evaluation which judged him to be cognitively competent for the
procedure. The patient was informed of and consented to the research protocol. SCS
placement was performed using a 32-electrode paddle array (CoverEdge™, Boston
Scientific, Marlborough, MA) implanted at the T7-9 vertebral levels, confirmed via
intraoperative fluoroscopy.
3.1 EMG RESPONSE DURING INTRAOPERATIVE SCS
SSEP collision testing during SCS was performed in order to ascertain the SCS
amplitude needed during 40 Hz LFTS to recruit underlying A fibers. SCS stimulation
began at 1.0 mA and increased in increments of 1.0 mA until attenuation of both P37
and N45 waveforms was witnessed via live recordings of cortical deflections using the
IOMAX stimulation and recording system. A stimulation amplitude of 4.0 mA was found
to be necessary for SSEP attenuation, shown in figure 19, in which the baseline cortical
responses are represented in white and cortical responses during SCS in purple.
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Using the SCS amplitude of 4.0 mA from SSEP collision testing, multiple SCS parameter
types were then tested while recording EMG from lower extremity muscles. Three

Figure 19: Cortical activity showing P37 and N45 waveforms during SSEP baseline testing (white) and during SSEP
anan
amplitude
of 4.0
mA mA
(purple)
collision testing
testing using
using40
40Hz
HzLFTS
LFTSatat
amplitude
of 4.0
(purple). Waveforms represent average response to
SSEP stimuli (n = 200).

stimulation parameters were chosen: LFTS - 40 Hz, 300 s, 4.0 mA, HFBS - 600 Hz
intraburst, 40 Hz interburst, 300 s, 4.0 mA and HFBS - 1200 Hz intraburst, 40 Hz
interburst, 140 s, 4.0 mA. LFTS at 40 Hz was chosen due to its high prevalence of use
for both pain mitigation and motor rehabilitation studies. HFBS at 600 Hz was selected
based on the hypothesis by Formento and colleagues that 600 Hz HFBS would optimally
preserve proprioceptive information based on primary afferent modeling.3 HFBS at 1200
Hz was also selected for testing due to the SCS system having a max frequency
capability of 1200
Hz.
Change in
baseline

EMG

activity

was

observed
HFBS

during

using

a

frequency of 600
Hz intraburst, 40
Hz interburst, 300
s

pulse

width
Figure 20: EMG response in Right Tibialis Anterior to varying SCS parameters at 4.0 mA.
Figure 20: EMG response in Right Tibialis Anterior to varying SCS parameters at 4.0
The onset of stimulation is represented with a red vertical line.
mA. The onset of stimulation is represented with a red vertical line.
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and amplitude of 4.0 mA. Figure 20 shows filtered EMG responses from the right TA to
40 Hz LFTS, 600 Hz HFBS and 1200 Hz HFBS. Voltage amplitudes of EMG response
are represented along the Y-axis while time is along the X-axis, where the red vertical
line indicates the start of SCS for each parameter set. Although EMG responses to right
tibialis anterior are shown, robust changes in EMG activity were observed in all recorded
musculature on the ipsilateral side of stimulation using the 600 Hz HFBS only.
3.2 EMG RESPONSE TO SCS DURING SENSORY T ESTING
Following thirty days of recovery, the subject returned for further SCS testing in
which subjective feedback could be documented. Sensory threshold testing (i.e.,
increasing SCS intensity until the subject perceives the stimulation) was performed with
similar SCS parameters used during intraoperative testing and are shown in Table 1
below.

Table 1: SCS parameters used for later EMG testing and corresponding amplitude necessary for subject to perceive
stimulation

Stimulation Type / Pulse width

Perceived Sensory Threshold Amplitude (mA)

40 Hz, LFTS / 140 s

9.6

600 Hz, HFBS, 40 Hz interburst / 140 s

3.7

1200 Hz, HFBS, 40 Hz interburst / 140 s

2.8

Although the stimulation types used during intraoperative investigation remained
constant, both 40 Hz LFTS and 600 Hz HFBS had pulse width standardized to 140 s to
more accurately compare effects among the different parameters. The subject reported
equal amounts of pain reduction among all three parameter types at the 1.5x perceived
sensory threshold level.

Using information obtained during extraoperative perceived

sensory threshold testing, we measured EMG responses to each parameter tested. SCS
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amplitudes were increased from sensory threshold, to 1.5x sensory threshold and up to
2.0x sensory threshold (beyond which the subject reported discomfort). EMG analysis
was performed on signals recorded at the 2.0x sensory threshold amplitude.
Figure 21 shows filtered EMG activity from the left soleus during individual
parameter testing of 40 Hz LFTS, 600 Hz HFBS and 1200 Hz HFBS, where EMG
voltage is represented along the Y-axis and time along the X-axis. Superimposed over
the raw EMG is a green vertical line showing the start of 1.5x sensory threshold SCS, a
red line showing
when

stimulation

amplitude reached
2x

sensory

threshold and a
blue box outlining
the region of EMG
analyzed

for

statistical testing.
Mean

amplitude

analysis

of

selected

EMG

showed

greater

activation

in

response to 600

Figure 19: Analysis of evoked potentials where Top) shows filtered EMG response to SCS,
Middle) a scatter plot of amplitude data for selected evoked potentials and, Bottom) mean
amplitude of selected potentials with standard error. * ( p < .001, Kruskal-Wallace )

Hz HFBS when compared to 40 Hz LFTS and 1200 Hz HFBS (p < 0.001, Kruskal-Wallis
test). Evoked potentials were not observed in the EMG data of either vastus lateralis or
tibialis anterior muscles during 1200 Hz HFBS, therefore no statistical analysis were
performed comparing those groups. In Table 2, the mean amplitude of evoked potentials
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for all muscles recorded along with mean interpeak interval calculated during HFBS and
LFTS testing are shown along with corresponding p-values.

Table 2:
Data collected during SCS testing at 2.0x sensory threshold with evoked potential amplitude, IPI and
corresponding p-values shown.
Muscle

Stimulation Type

SCS
amplitude
(mA)

mean amplitude
(microvolts)

40 Hz, LFTS

19.2

33.7 ± 0.7

p-value

mean IPI (ms)

p-value

Group 1
Vastus
Lateralis (VL)
VL

302.6 ± 11.3
< .01

600 Hz, HFBS, 40
Hz interburst

7.4

122.1 ± 2.5

40 Hz, LFTS

19.2

39.2 ± 0.8

< .01
54.4 ± 1.3

Group 2
Tibialis
Anterior (TA)
TA

296.1 ± 71.1
< .01

< .01

600 Hz, HFBS, 40
Hz interburst

7.4

69.7 ± 0.9

54.5 ± 0.3

Soleus (SOL)

40 Hz, LFTS

19.2

90.4 ± 1.2

33.5 ± 0.4

SOL

600 Hz, HFBS, 40
Hz interburst
1200 Hz, HFBS, 40
Hz interburst

7.4

143.0 ± 2.6

5.6

44.9 ± 1.9

Group 3

SOL

< .01

25.4 ± 0.2

< .01

87.7 ± 4.4
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3.3 DIFFERENCES IN PASSIVE M OTION DETECTION
Due to prolonged SCS activation at 2.0x sensory threshold, the TTDPM test was
completed using stimulation amplitudes at 1.5x sensory threshold for the 40Hz LFTS
and 600 Hz HFBS
parameters.

Figure

22 shows results of
the TTDPM among
the

three

testing

conditions being 1)
no

stimulation,

2)

600 Hz intraburst, 40
Hz

interburst,

140

s, 7.4 mA and, 3)
40 Hz, 140 s, 14.4
mA. Results from a
one-way ANOVA test
for the 10 trials per
tested

condition

Figure 20: Results from the TTDPM showing, Top) illustration of the TTDPM testing
process,
Middle)
a scatter
plotTTDPM
of recorded
degrees
passive flexion/extension
before
Figure 22:
Results
from the
showing,
Top)ofillustration
of the TTDPM testing
detection
and Bottom)
mean
degrees
of knee
flexion/extension
applied before
process, Middle)
a scatter
plot
of recorded
degrees
of passive passively
flexion/extension
subject
recognizes
movement.
* ( p < .001,
One-way
Anova)
detection
and Bottom)
mean degrees
of knee
flexion/extension
passively applied before
subject recognizes movement.

indicate a non-significant difference between no stimulation and the HFBS parameter
set, with a significant difference existing between LFTS and the other two testing
conditions (p < .001).
3.4 DIFFERENCES IN M ODULE CLASSIFICATION AND KINEMATICS
Muscle activation patterns and kinematic features observed during gait can be
quantified by a measure known as EMG moduling complexity. We compared EMG
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moduling complexity in our subject in response to no stimulation, 40 Hz LFTS and 600
Hz HFBS (performed at 1.5x sensory threshold for each stimulation parameter).
Figure 23 displays the muscle weightings among the 4 classified modules,
corresponding to the 4 components of the gait cycle identified by Clark: early stance, late

Figure 23:
21: Results from EMG module classification showing muscle activation patterns among various testing
conditions where it may be seen that muscle co-activations during functional task are similar

stance, early swing and late swing. EMG was normalized to the highest activated muscle
(value of 1.0). Normalized EMG amplitudes per module are located along the Y-axis,
while individual muscles (i.e., channels) are located along the X-axis. The classification
of EMG modules (See 1.6, 2.4) was found to have no change among the tested
conditions of 1) no stimulation, 2) 600 Hz intraburst, 40 Hz interburst, 140 s, 7.4 mA
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and, 3) 40 Hz, 140 s, 14.4 mA. All parameters tested resulted in a module complexity
classification of 4 modules, which represents the highest moduling complexity.
Although EMG activity during walking did not deviate among the tested
conditions in large enough amounts for the NNMF algorithm to differentially assign
module classification, further investigation of the raw EMG during walking showed
observable
differences

in

muscle firing among
the

different

SCS

trials and baseline
testing. Figure 24
shows
amplitude

EMG
(Y-axis)

of left TA averaged
across all completed
gait
(normalized

cycles
by

percentage of the

Figure 22: EMG recorded from the left tibialis anterior through each testing condition.
EMG signal is average of all gait cycles during each tested condition.

cycle) for each stimulation parameter tested, where TA activity during HFBS (blue) more
closely resembles TA activity during no stimulation (green) than TA activity during LFTS
(red) throughout most of the cycle. Specifically, between 50 and 60 % of the gait cycle,
the pre-swing phase is where TA activity should be minimal allowing proper
plantarflexion and propulsion.
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Figure 24 shows results in line with this estimation.

Baseline gait EMG signal amplitude falls dramatically during this interval, as does the
amplitude during HFBS but not LFTS.
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Regarding gait kinematics, significant difference was observed in step height for
both the left and right foot, with HFBS more closely resembling baseline height for the
left and right side. Figure 25 shows the gait cycle beginning with right heel strike at 0%
and ending with the next recurring right heel strike at 100%, where a red box has been
placed around the mid-swing phase at approximately 80% of the gait cycle where foot
height should reach a maximum.

Figure 25:
23: image a caption modified from [40].
[38]. Illustration of appropriate kinematics during the gait cycle

Figure 26 shows several traces of foot height in meters (Y-axis) over 100% of the
gait

cycle

(X-axis)

during no stimulation
(baseline),

HFBS

and LFTS averaged
over all completed
gait

cycles

shaded

with
regions

representing
standard

error.

A

non-significant
difference, using a
one-way

ANOVA,

Figure 26:
24: Height measurement during gait in meters of the Top) left foot with standard
error and, Bottom) right foot with standard error.
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exists between baseline testing conditions and trials during HFBS (p > 0.05), and a
significant difference exists between baseline conditions and trials during LFTS with a pvalue of < .05 and < .01 for left and right foot height, respectively.
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4.0 DISCUSSION
Results from SCS parameter testing during intraoperative stimulator placement
under general anesthesia, awake sensory threshold testing at rest during EMG recording
and dynamic walking task during EMG and motion capture suggest that HFBS and LFTS
differ in several important aspects. Specifically, 600 Hz HFBS may have the unique
capacity to influence motor pathways of the spinal cord without significantly disrupting
sensory afferent signaling or significantly impacting movement dynamics during a
functional task. This could be an important advance in the motor rehabilitation field if this
result can be replicated in more patients with chronic pain and motor deficits, because it
points to a possible mechanism of selective sparing of proprioceptive input when
engaging motor tasks.
Observations made during intraoperative testing show that LFTS at amplitudes
necessary to recruit A fibers, seen during the SSEP collision protocol, are not sufficient
enough to recruit lower motoneurons (MN) of the ventral horn of the spinal cord (VHSC).
This was also true at the maximum device stimulation frequency of 1200 Hz, regardless
of burst or nonburst stimulation pattern. In contrast, 600 Hz HFBS produced robust and
sustained activity in the EMG from all three lower extremity muscles indicating the ability
to influence downstream targets of the VHCS across multiple spinal levels. The ability of
600 Hz HFBS to accomplish this task, and the inability of 40 Hz LFTS, may be due to the
ability of neurons to interpret multiple small amplitude stimuli in high frequency as one
large stimulus given in a single pulse. While the principle of temporal summation may be
able to account for the difference in HFBS and LFTS, it would not necessarily explain
why 600 Hz HFBS and 1200 Hz HFBS do not produce similar results.
One possible explanation for the difference between 600 Hz and 1200 Hz HFBS
to recruit VHSC motoneurons might be a phenomenon known as synaptic fatigue, where
rapid stimuli producing fast trains of action potentials lead to a decay in post synaptic
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activity, which in this case might implicate the role of interneurons located within the
superficial dorsal horn of the spinal cord (DHSC). Synaptic fatigue is generally thought to
occur due to an inability to endocytose vesicles containing neurotransmitters in a rapid
enough fashion to entrain excitation to neighboring post synaptic densities. However, it
should also be noted that limitations in stimulator technology did not allow for 1200 Hz
HFBS to be delivered with a 300 s pulse width, which was used during 600 Hz HFBS,
and instead was restricted to a 140 s pulse width which may have impacted the ability
to recruit underlying A fibers.
The ability of 600 Hz HFBS to recruit A fibers at smaller amplitudes than LFTS
may explain the ability of HFBS to allow the subject to sense a passive change in knee
angle in a manner more closely resembling baseline capacity than LFTS. A previous
study observed that axonal recruitment via SCS is primarily dependent upon stimulation
amplitude and pulse width, with increases in either parameter leading to production of
larger electric fields influencing more underlying neuronal structures.3 It is possible that
the unique combination of 600 Hz intraburst patterning with a 40 Hz interbust interval
represents a stimulus within the functional and/or optimal ranges of both sensory
pathways (i.e., pain and proprioception) to allow inhibition of the former and preservation
of the latter.
Although a significant difference in EMG module complexity was not observed
between stimulus modalities, the findings from proprioceptive testing during TTDPM may
shed light on observed differences in raw EMG activity of certain muscles during the
walking task. TA activity was seen to be active at inappropriate times during LFTS,
which was not observed during HFBS. Specifically, TA activity during the late stance
phase of the gait cycle was elevated compared to HFBS and no stimulation trials and
may contribute to a lack of propulsion during gait. We speculate that the interference in
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proprioceptive signaling observed during TTDPM may have led to TA activity being
improperly regulated by sensory afferents normally responsible for inhibition of
antagonistic flexor activity during extension. Similar dysregulation, although not
observed, may also be responsible for the lack of foot height through gait seen during
LFTS and may account for the similarity between baseline trials with no stimulation and
trials during HFBS. These findings highlight increased interest in neuromodulation of
sensorimotor pathways using lower thoracic SCS, where a current clinical trial
(NCT03586882) is investigating the effect of SCS on gait and balance in subjects with
chronic pain.
Possible limitations of the presented study also warrant discussion. The potential
of SCS to influence sensorimotor pathways of the spinal cord after stimulation has
ended is not well understood and not explored in this study. For instance, various forms
of neuromodulation of the cerebrum lead to carryover effects lasting longer than the
duration of modulation. It is plausible that neuromodulation of the spinal cord may share
similar principles and presented data may not represent, exclusively, effects of a single
parameter type. Furthermore, data collection during intraoperative investigation was
limited to 20 minutes and limited the ability to explore a larger parameter space of the
SCS system. Finally, as highlighted previously, our findings represent data from only one
individual.
In conclusion, we found in one subject that HFBS simultaneously activates more
muscle groups and spares more proprioceptive signals than LFTS, which is a classical
form of stimulation used in past investigations of motor recovery after spinal cord injury.
It is shown that HFBS has the ability to recruit lower MNs at 1) lower stimulation
amplitude 2) without disrupting proprioceptive signaling and 3) without influencing
physiologically and kinematically appropriate mechanisms involved with human gait.
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